m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer-Reference-Cited by-同舟云学术

m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer

Published:2021-01-01 Issue:1 Volume:12 Page:3159-3176
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Zhang Cheng¹,Liu JinHui²^ORCID,Guo Hongyu²,Hong Dandan¹,Ji Jing¹,Zhang Qin¹,Guan Qun¹,Ren Qingling¹

Affiliation:

1. Department of Gynecology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029 Jiangsu, China

2. Department of Gynecology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029 Jiangsu, China

Funder

funding to report

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1946305

Reference94 articles.

1. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2

2. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA

3. METTL3 promotes ovarian carcinoma growth and invasion through the regulation of AXL translation and epithelial to mesenchymal transition

4. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer

5. The interplay between m6A RNA methylation and noncoding RNA in cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of m6A Methylation in Tumor Immunity and Immune-Associated Disorder;Biomolecules;2024-08-22

2. Manipulating the tumour immune microenvironment by N6-methyladenosine RNA modification;Cancer Gene Therapy;2024-06-04

3. N6-Methyladenosine–Modified KREMEN2 Promotes Tumorigenesis and Malignant Progression of High-Grade Serous Ovarian Cancer;Laboratory Investigation;2024-06

4. Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects;Frontiers in Oncology;2024-03-13

5. Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer;Cancer Control;2024-01